Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,66 USD | +1,14 % | +0,38 % | +12,24 % |
01/03 | Kinnate Biopharma vend ses actifs de traitement du cancer aux Laboratoires Pierre Fabre | MT |
26/02 | KINNATE BIOPHARMA INC. : Stifel Nicolaus confirme sa recommandation neutre | ZM |
Métier
Nombre d'employés: 84
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Nima Farzan
CEO | Chief Executive Officer | 48 | 01/03/20 |
Director of Finance/CFO | 37 | 07/06/21 | |
Quah Cheng
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/06/20 |
Mark Meltz
COO | Chief Operating Officer | 50 | 01/04/20 |
Priyanka Shah
IRC | Investor Relations Contact | - | - |
Barbara Warren
HRO | Human Resources Officer | - | 01/01/21 |
Jason Hampson
LAW | General Counsel | - | 07/06/21 |
David Madden
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dean Mitchell
CHM | Chairman | 68 | 09/09/20 |
James Tananbaum
BRD | Director/Board Member | 59 | 01/06/20 |
Carl Gordon
BRD | Director/Board Member | 59 | 01/12/19 |
Melissa Epperly
BRD | Director/Board Member | 46 | 01/10/20 |
Laurie Alsup
BRD | Director/Board Member | 70 | 01/08/20 |
Jill DeSimone
BRD | Director/Board Member | 68 | 01/03/23 |
Keith Flaherty
BRD | Director/Board Member | 53 | 01/12/19 |
Nima Farzan
CEO | Chief Executive Officer | 48 | 01/03/20 |
Helen Sabzevari
BRD | Director/Board Member | 62 | 24/06/21 |
Michael Rome
BRD | Director/Board Member | 39 | 01/12/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 47 166 421 | 33 314 639 ( 70,63 %) | 0 | 70,63 % |
Coordonnées société
Kinnate Biopharma, Inc.
12830 El Camino Real Suite 150
92130, San Diego
+858 299 4699
http://www.kinnate.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+12,24 % | 126 M | |
+9,16 % | 45,97 Md | |
+54,26 % | 43,93 Md | |
+11,20 % | 42,34 Md | |
-8,59 % | 28,27 Md | |
+16,40 % | 27,18 Md | |
-19,34 % | 19,44 Md | |
+13,95 % | 13,83 Md | |
+31,56 % | 12,4 Md | |
+10,63 % | 11,45 Md |
- Bourse
- Actions
- Action Kinnate Biopharma Inc. - Nasdaq
- Société Kinnate Biopharma Inc.